Theophylline Antibodies

Santa Cruz Biotechnology offers a broad range of Theophylline monoclonal antibodies for various research applications. Theophylline Antibodies targeting Theophylline are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Theophylline is a methylxanthine derivative that plays a crucial role in the treatment of respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), by acting as a bronchodilator. The mechanism of action involves inhibiting phosphodiesterase, leading to increased levels of cyclic AMP, which relaxes bronchial smooth muscle. Understanding Theophylline's function and regulation is essential for developing effective therapeutic strategies and improving patient outcomes. Theophylline Antibodies enable researchers to investigate Theophylline's distribution and interactions within cellular environments. Advanced research techniques utilizing Theophylline monoclonal antibodies help reveal new insights about cellular signaling pathways and therapeutic mechanisms. Theophylline Antibodies from Santa Cruz Biotechnology support the scientific community in advancing respiratory disease research and therapeutic development.